Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 3/2003

01-03-2003 | Original Article

Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties

Authors: Jörg Westermann, Ida J. Körner, Joachim Kopp, Steffen Kurz, Martin Zenke, Bernd Dörken, Antonio Pezzutto

Published in: Cancer Immunology, Immunotherapy | Issue 3/2003

Login to get access
Metadata
Title
Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional properties
Authors
Jörg Westermann
Ida J. Körner
Joachim Kopp
Steffen Kurz
Martin Zenke
Bernd Dörken
Antonio Pezzutto
Publication date
01-03-2003
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 3/2003
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-002-0355-6

Other articles of this Issue 3/2003

Cancer Immunology, Immunotherapy 3/2003 Go to the issue

Original Article

Analysis of in vitro immunization: generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells

Original Article

Exposure to paclitaxel or vinblastine down-regulates CD11a and CD54 expression by P815 mastocytoma cells and renders the tumor cells resistant to killing by nonspecific cytotoxic T lymphocytes induced with anti-CD3 antibody

Review

IL-12: a promising adjuvant for cancer vaccination

Original Article

Melphalan-induced up-regulation of B7–1 surface expression on normal splenic B cells

Original Article

Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside

Original Article

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits